Fatty acid formulations and methods of use thereof

A dietary formulation suitable for treating an autism spectrum disorder and/or apraxia, the formulation comprising:

• a) eicosapentaenoic acid (EPA);
• b) docosohexaenoic acid (DHA);
• c) α-tocopherol;
• d) γ-tocopherol;
• e) vitamin K1;
• f) vitamin K2;
• and
• g) γ-linolenic acid (GLA),
• wherein the ratio of EPA to DHA is in a range of from 1.5:1 to 5:1,
• wherein the α-tocopherol is present in an amount of from 300 mg to 3000 mg per unit dose,
• wherein the γ-tocopherol is present in an amount of from 200 mg to 1000 mg per unit dose,
• wherein the EPA is present in an amount of from 500 mg to 3000 mg per unit dose,
• wherein the DHA is present in an amount of from 100 mg to 400 mg per unit dose,
• wherein the vitamin K1 is present in an amount of from 100 μg to 10 mg,
• wherein the vitamin K2 is present in an amount of from 100 μg to 2 mg;
• and
• wherein the GLA is present in an amount of from 50 mg to 75 mg.